Incidence of and Ivermectin Prescription Trends for COVID-19 in Japan
J Gen Intern Med
.
2023 Mar;38(4):1078-1080.
doi: 10.1007/s11606-022-07877-8.
Epub 2022 Nov 2.
Authors
Takashi Watari
1
2
,
Yasuharu Tokuda
3
4
,
Kiyosu Taniguchi
5
,
Kenji Shibuya
4
Affiliations
1
Shimane University Hospital, General Medicine Center, Shimane University, 89-1, Enya-cho, Izumo shi, Shimane, 693-8501, Japan.
[email protected]
.
2
Division of Hospital Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
[email protected]
.
3
Muribushi Okinawa Clinical Training Center, Urasoe, Okinawa, Japan.
4
Tokyo Foundation for Policy Research, Tokyo, Japan.
5
National Hospital Organization Mie National Hospital, Tsu, Mie, Japan.
PMID:
36323824
PMCID:
PMC9629759
DOI:
10.1007/s11606-022-07877-8
No abstract available
MeSH terms
COVID-19*
Humans
Incidence
Ivermectin / therapeutic use
Japan / epidemiology
Substances
Ivermectin